Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
2.840
-0.590 (-17.20%)
Sep 11, 2025, 2:31 PM EDT - Market open
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $51.94 million as of September 11, 2025. Its market cap has decreased by -36.89% in one year.
Market Cap
51.94M
Enterprise Value
49.64M
1-Year Change
-36.89%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $51.94M, a decrease of -75.12%. That is a compound annual growth rate of -31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 62.73M | -21.15% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |